HC Wainwright maintains Intellia Therapeutics $25 price target
HC Wainwright & Co. maintained its $25.00 per share price target for Intellia Therapeutics,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.